[\'Libentech Co. LTD, Daejeon, Republic of Korea.\', \'Department of Biological Sciences, College of Natural Sciences, Inha University, Incheon, Republic of Korea.\']
The human ACE-2 receptor binding domain of SARS-CoV-2 express on the viral surface of the Newcastle disease virus as a non-replicating viral vector vaccine candidate.